Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (28)
Multiple-Drug Resistance in Human Cancer
1987 • 703 citations
Rationale for the use of alternating non-cross-resistant chemotherapy.
1982 • 545 citations
Secondary Acute Myeloid Leukemia in Children Treated for Acute Lymphoid Leukemia
1989 • 457 citations
Four-Agent Induction and Intensive Asparaginase Therapy for Treatment of Childhood Acute Lymphoblastic Leukemia
1986 • 432 citations
The Effectiveness of Combinations of Antileukemic Agents in Inducing and Maintaining Remission in Children with Acute Leukemia
1965 • 314 citations
Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study
1990 • 264 citations
Philadelphia chromosome positive childhood acute lymphoblastic leukemia: clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study
1990 • 228 citations
A direct bone marrow chromosome technique for acute lymphoblastic leukemia
1984 • 193 citations
Results and Significance of Six Randomized Trials in Four Consecutive ALL-BFM Studies
1990 • 188 citations
Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer
1990 • 170 citations
Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study
1990 • 126 citations
Clinical pharmacology of intrathecal methotrexate. II. An improved dosage regimen derived from age-related pharmacokinetics.
1977 • 114 citations
Correlation of karyotype and immunophenotype in childhood acute lymphoblastic leukemia.
1988 • 105 citations
Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study
1990 • 95 citations
Age at diagnosis in childhood acute lymphoblastic leukemia
1986 • 84 citations
Prognostic importance of the pre-B-cell immunophenotype and other presenting features in B-lineage childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study
1989 • 77 citations
Clinical and biologic features predict poor prognosis in acute lymphoid leukemias in children and adolescents: A pediatric oncology group review
1986 • 76 citations
High‐dose methotrexate improves clinical outcome in children with acute lymphoblastic leukemia: St. Jude total therapy study X
1988 • 68 citations
Molecular heterogeneity in acute leukemia lineage switch
1989 • 67 citations
Prognostic importance of the pre-B-cell immunophenotype and other presenting features in B-lineage childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study
1989 • 55 citations
Teniposide plus cytarabine improves outcome in childhood acute lymphoblastic leukemia presenting with a leukocyte count greater than or equal to 100 x 10(9)/L.
1987 • 45 citations
Clinical pharmacodynamics of anticancer drugs: a basis for extending the concept of dose-intensity
1988 • 43 citations
Intermediate dose methotrexate in childhood acute lymphocytic leukemia
1984 • 41 citations
Variation by race in presenting clinical and biologic features of childhood acute lymphoblastic leukaemia: Implications for treatment outcome
1985 • 40 citations
The Cytogenetics of Childhood Leukemia: Clinical and Biologic Implications
1988 • 25 citations
Early results of intensified remission induction chemotherapy for childhood acute lymphocytic leukemia
1986 • 21 citations
Limiting Toxicities During Intensified Remission Induction Chemotherapy for Childhood Acute Lymphocytic Leukemia
1987 • 8 citations
Rapidly rotating combination chemotherapy in childhood acute lymphoblastic leukemia: preliminary results of a randomized comparison with conventional treatment.
1988 • 8 citations
Cited By (0)
No citing papers found in database